Key Statistics for CRL
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CRL
- Net Income (M/USD)
Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company pro- vides the animal research models required in research and development for new drugs, devices, and therapies. Charles River's customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.
More Company Profile & Key Executives for CRL
|James C FosterChairman/President/CEO||Thomas F AckermanExec VP/CFO|
|Nancy A GillettExec VP/Chief Scientific Ofcr||David P JohstExec VP:HR/CAO/Secy/Gen Cnsl|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries